153 related articles for article (PubMed ID: 37031717)
1. Higher Respiratory Complications in Alcoholic Hepatitis Patients With Hepatorenal Syndrome When Treated With Terlipressin: Is it Safe?
Ariga KK; Verma G; Agrawal D
Clin Gastroenterol Hepatol; 2023 Nov; 21(12):3197-3198. PubMed ID: 37031717
[No Abstract] [Full Text] [Related]
2. Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis.
Sigal SH; Sanyal AJ; Frederick RT; Weinberg EM; Pappas SC; Jamil K
Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3455-3457.e3. PubMed ID: 36848979
[No Abstract] [Full Text] [Related]
3. Terlipressin may influence the outcome of hepatorenal syndrome complicating alcoholic hepatitis.
Cervoni JP; Lecomte T; Cellier C; Auroux J; Simon C; Landi B; Gadano A; Barbier JP
Am J Gastroenterol; 1997 Nov; 92(11):2113-4. PubMed ID: 9362205
[TBL] [Abstract][Full Text] [Related]
4. Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: PRO.
Belcher JM
Kidney360; 2024 Jun; 5(6):791-794. PubMed ID: 38526157
[No Abstract] [Full Text] [Related]
5. Reply: Is right heart assessment vital for evaluating terlipressin-related outcomes in hepatorenal syndrome-acute kidney injury?
Roy A; Kajal K; Izzy M; Sihag BK; Premkumar M
Hepatology; 2024 Jun; 79(6):E163-E164. PubMed ID: 38441911
[No Abstract] [Full Text] [Related]
6. Letter to the Editor: Is right heart assessment vital for evaluating terlipressin-related outcomes in hepatorenal syndrome-acute kidney injury?
Guo Q; Wang J; Wang G; Wang X
Hepatology; 2024 Jun; 79(6):E161-E162. PubMed ID: 38456783
[No Abstract] [Full Text] [Related]
7. Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence.
Zhang J; Rössle M; Zhou X; Deng J; Liu L; Qi X
Curr Med Res Opin; 2019 May; 35(5):859-868. PubMed ID: 30474439
[TBL] [Abstract][Full Text] [Related]
8. Board Review Vignette: Lessons Learned in the Management of Hepatorenal Syndrome Type 1 With Terlipressin.
Gonzalez SA; Velez JCQ
Am J Gastroenterol; 2022 Apr; 117(4):520-523. PubMed ID: 35029160
[No Abstract] [Full Text] [Related]
9. Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis.
Wang H; Liu A; Bo W; Feng X; Hu Y
Medicine (Baltimore); 2018 Apr; 97(16):e0431. PubMed ID: 29668606
[TBL] [Abstract][Full Text] [Related]
10. Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.
Kim HR; Lee YS; Yim HJ; Lee HJ; Ryu JY; Lee HJ; Yoon EL; Lee SJ; Hyun JJ; Jung SW; Koo JS; Choung RS; Lee SW; Choi JH
Clin Mol Hepatol; 2013 Dec; 19(4):417-20. PubMed ID: 24459647
[TBL] [Abstract][Full Text] [Related]
11. First Drug for Treating Hepatorenal Syndrome.
Aschenbrenner DS
Am J Nurs; 2023 Feb; 123(2):27. PubMed ID: 36698358
[TBL] [Abstract][Full Text] [Related]
12. Terlipressin for hepatorenal syndrome: opportunities and challenges.
Singal AK; Jalan R
Lancet Gastroenterol Hepatol; 2023 Feb; 8(2):104-106. PubMed ID: 36620975
[No Abstract] [Full Text] [Related]
13. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.
Neri S; Pulvirenti D; Malaguarnera M; Cosimo BM; Bertino G; Ignaccolo L; Siringo S; Castellino P
Dig Dis Sci; 2008 Mar; 53(3):830-5. PubMed ID: 17939047
[TBL] [Abstract][Full Text] [Related]
14. Terlipressin for hepatorenal syndrome.
Wong F
Curr Opin Gastroenterol; 2024 May; 40(3):156-163. PubMed ID: 38353275
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome.
Velez JCQ; Wong F; Reddy KR; Sanyal AJ; Vargas HE; Curry MP; Gonzalez SA; Pappas SC; Jamil K
Kidney360; 2023 Aug; 4(8):1030-1038. PubMed ID: 37143199
[TBL] [Abstract][Full Text] [Related]
16. Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: CON.
Willows J; Hiremath S
Kidney360; 2024 Jun; 5(6):795-798. PubMed ID: 38526155
[No Abstract] [Full Text] [Related]
17. Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: COMMENTARY.
Allegretti AS
Kidney360; 2024 Jun; 5(6):799-801. PubMed ID: 38526154
[No Abstract] [Full Text] [Related]
18. [Research progress of terlipressin in the treatment of cirrhotic ascites-related complications].
Liu CH; Xing F; Wang J
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):929-932. PubMed ID: 31941255
[TBL] [Abstract][Full Text] [Related]
19. Respiratory events with terlipressin and albumin in hepatorenal syndrome: A review and clinical guidance.
Allegretti AS; Subramanian RM; Francoz C; Olson JC; Cárdenas A
Liver Int; 2022 Oct; 42(10):2124-2130. PubMed ID: 35838488
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis: terlipressin therapy for the hepatorenal syndrome.
Fabrizi F; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Sep; 24(6):935-44. PubMed ID: 16948805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
